STERIS plc financial data

Symbol
STE on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
70 Sir John Rogerson's Quay, Dublin, Ireland
State of incorporation
Ireland
Fiscal year end
March 31
Former names
STERIS Ltd (to 3/28/2019)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 257 % +7.35%
Quick Ratio 83.7 % -0.92%
Debt-to-equity 66.7 % -14.9%
Return On Equity 6.76 % -24.7%
Return On Assets 4.06 % -19.5%
Operating Margin 16 % -42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98.7M shares -0.09%
Common Stock, Shares, Outstanding 98.7M shares -0.08%
Common Stock, Value, Issued 4.49B USD -0.62%
Weighted Average Number of Shares Outstanding, Basic 98.7M shares -0.12%
Weighted Average Number of Shares Outstanding, Diluted 99.2M shares -0.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.33B USD +10.6%
Cost of Revenue 750M USD +8.4%
Research and Development Expense 105M USD +5.57%
Operating Income (Loss) 852M USD -35.9%
Nonoperating Income (Expense) -102M USD +20.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 750M USD +7.56%
Income Tax Expense (Benefit) 157M USD +18.1%
Net Income (Loss) Attributable to Parent 435M USD -20.9%
Earnings Per Share, Basic 4.4 USD/shares -20.7%
Earnings Per Share, Diluted 4.38 USD/shares -20.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 172M USD -19.4%
Accounts Receivable, after Allowance for Credit Loss, Current 923M USD -1.81%
Inventory, Net 689M USD -16.1%
Assets, Current 1.94B USD -10.9%
Property, Plant and Equipment, Net 1.93B USD +10.7%
Operating Lease, Right-of-Use Asset 159M USD -17.2%
Intangible Assets, Net (Excluding Goodwill) 2B USD -34.5%
Goodwill 4.15B USD +2.75%
Other Assets, Noncurrent 60.3M USD -17%
Assets 10.2B USD -9.21%
Accounts Payable, Current 235M USD -19.9%
Employee-related Liabilities, Current 147M USD +8.16%
Accrued Liabilities, Current 307M USD +0.27%
Liabilities, Current 805M USD -7.75%
Accrued Income Taxes, Noncurrent 6.53M USD -35.4%
Operating Lease, Liability, Noncurrent 146M USD +4.49%
Other Liabilities, Noncurrent 74.2M USD -3.13%
Liabilities 3.63B USD -28.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -166M USD +57.1%
Retained Earnings (Accumulated Deficit) 2.27B USD +10.9%
Stockholders' Equity Attributable to Parent 6.59B USD +6.72%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.61B USD +6.81%
Liabilities and Equity 10.2B USD -9.21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 304M USD +8.04%
Net Cash Provided by (Used in) Financing Activities -999M USD -368%
Net Cash Provided by (Used in) Investing Activities 688M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 98.9M shares +0.26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.69M USD -3482%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 172M USD -19.4%
Deferred Tax Assets, Valuation Allowance 26.4M USD +29.8%
Deferred Tax Assets, Gross 228M USD +10.9%
Payments to Acquire Property, Plant, and Equipment 108M USD +62.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 656M USD -13.9%
Lessee, Operating Lease, Liability, to be Paid 217M USD -10.2%
Property, Plant and Equipment, Gross 3.6B USD +10.5%
Operating Lease, Liability, Current 30.5M USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 32.6M USD -2.94%
Lessee, Operating Lease, Liability, to be Paid, Year One 37.9M USD -9.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +26.3%
Deferred Income Tax Expense (Benefit) -22.1M USD -4871%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39.8M USD -13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.1M USD -11.6%
Deferred Tax Assets, Operating Loss Carryforwards 37.1M USD -1.52%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 2.15M USD -3.59%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.7M USD -5.07%
Depreciation, Depletion and Amortization 113M USD -18.3%
Deferred Tax Assets, Net of Valuation Allowance 202M USD +8.83%
Interest Expense 142M USD +21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%